Quick Answer
BICYCLE THERAPEUTICS PLC reported R&D Expense of $240.28 million for fiscal year 2025.
BICYCLE THERAPEUTICS PLC R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $240.28M | +38.9% |
| 2024 | $172.97M | +10.5% |
| 2023 | $156.50M | +91.8% |
| 2022 | $81.61M | +81.8% |
| 2021 | $44.88M | +35.4% |
| 2020 | $33.15M | +29.8% |
| 2019 | $25.54M | +23.0% |
| 2018 | $20.76M | +75.0% |
| 2017 | $11.87M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $58.43M | +21.1% | -17.7% |
| June 30, 2025 | $71.03M | +77.3% | +20.3% |
| March 31, 2025 | $59.06M | +69.4% | +22.4% |
| September 30, 2024 | $48.27M | +21.1% | +20.5% |
| June 30, 2024 | $40.06M | +0.9% | +14.9% |
| March 31, 2024 | $34.86M | +8.2% | -12.6% |
| September 30, 2023 | $39.87M | +75.2% | +0.4% |
| June 30, 2023 | $39.72M | +100.1% | +23.3% |
- BICYCLE THERAPEUTICS PLC showed an increase of +38.9% in R&D Expense compared to the prior fiscal year.
- Over the 2017–2025 period, BICYCLE THERAPEUTICS PLC’s r&d expense has grown by 1925.0% (from $11.87 million to $240.28 million).
- The most recent figure is from BICYCLE THERAPEUTICS PLC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: